Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitachontin is a multi-ingredient vitamin and joint health supplement developed and marketed by Kolon Pharma in South Korea. It is available in formulations such as Vitachontin 600 and Vitachontin 800, which combine chondroitin sulfate sodium with a comprehensive blend of B-complex vitamins (including fursultiamine, benfotiamine, riboflavin, nicotinamide, calcium pantothenate, pyridoxine, and cyanocobalamin/mecobalamin) and other supportive nutrients like gamma oryzanol, choline bitartrate, and inositol. Vitachontin is approved for the relief of joint pain (arthralgia), neuralgia, muscle pain (myalgia), and physical fatigue, as well as for supplementing essential vitamins during periods of increased physical demand, pregnancy, or recovery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vitachontin.